Triple Agonist 14mg — Verification Report

From Sunrise BioResearch · Lot GLP3140426 · Tested April 2026

← Back to Sunrise BioResearch

VialTalk

Verification report

Triple Agonist 14mg

Sunrise BioResearch

Score

105.5

Grade

A++

Superlative

Lot GLP3140426

Tested April 2026

Report ID

7f39b820

Test

Method

Result

Status

PurityFull credit

HPLC

99.5%

Full credit

IdentityFull credit

Mass spectrometry

Confirmed

Full credit

ContentStrong

Gravimetric vs label claim

14 mg labeled · 14.63 mg tested

Strong

EndotoxinFull credit

USP <85> compendial

Screened

Full credit

Heavy metalsFull credit

USP <232>/<233> compendial

Screened

Full credit

SterilityFull credit

USP <71> compendial

Screened

Full credit

Batch conformityPartial

Two-plus vials, per vial

Assessed

Partial

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →